ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Ohio State Wins P01 Grant

December 6, 2002

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998